斯塔格特病的ABC:精准医学的最新进展
Yasmine A Zaydon1, Stephen H Tsang2,3,4
1Departments of Ophthalmology, Pathology and Cell Biology, Jonas Children's Vision Care, and Bernard and Shirlee Brown Glaucoma Laboratory, Columbia Stem Cell Initiative, Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA. yaz2103@columbia.edu.
Cell & bioscience
|July 26, 2024
概括
星格特病 (STGD) 是由ABCA4基因变异引起的青少年黄斑变症,具有治疗挑战. 基因治疗和干细胞等新兴疗法在正在进行的临床试验中显示出有希望的结果.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 再生医学是一种再生医学.
背景情况:
- 斯塔格特病 (STGD) 是主要的遗传性青少年黄斑变质症.
- 由ABCA4基因的序列变异引起的STGD表现出遗传复杂性和可变的表型.
- 在了解STGD的分子和临床方面,在过去十年中取得了重大进展.
研究的目的:
- 评估新兴的Stargardt疾病治疗策略.
- 审查当前的临床试验和精准医学对STGD的方法.
- 突出针对视觉循环,遗传缺陷和视网膜再生的治疗方法.
主要方法:
- 对Stargardt病最近的临床试验的审查.
- 对药理学,基因疗法和干细胞方法的评估.
- 对精准医学策略在性病治疗中的分析.
主要成果:
- 针对视觉周期的药理疗法正在出现,以减少视网膜损伤.
- 基因治疗有可能纠正特定的ABCA4基因缺陷.
- 干细胞疗法正在研究在STGD患者的视网膜再生.
结论:
- 多种治疗途径,包括药物,基因和干细胞疗法,正在为Stargardt病发展.
- 目前正在进行的临床试验和精准医学对于开发有效的STGD治疗至关重要.
- 针对视觉循环,遗传缺陷和视网膜再生,为管理STGD提供了希望.
相关概念视频
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K